Suppr超能文献

相似文献

1
The Role of PIAS SUMO E3-Ligases in Cancer.
Cancer Res. 2017 Apr 1;77(7):1542-1547. doi: 10.1158/0008-5472.CAN-16-2958. Epub 2017 Mar 22.
3
PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.
Biochem Soc Trans. 2007 Dec;35(Pt 6):1405-8. doi: 10.1042/BST0351405.
4
Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2872-7. doi: 10.1073/pnas.052559499. Epub 2002 Feb 26.
5
A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.
Oncogene. 2007 Oct 11;26(46):6665-76. doi: 10.1038/sj.onc.1210486. Epub 2007 May 28.
6
HIF-1α SUMOylation affects the stability and transcriptional activity of HIF-1α in human lens epithelial cells.
Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1279-90. doi: 10.1007/s00417-015-2999-x. Epub 2015 Apr 16.
8
Super-resolution study of PIAS SUMO E3-ligases in hippocampal and cortical neurons.
Eur J Histochem. 2021 Aug 11;65(s1):3241. doi: 10.4081/ejh.2021.3241.
9
The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Biol Cell. 2012 May;104(5):287-96. doi: 10.1111/boc.201100116. Epub 2012 Mar 7.
10
SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
J Cell Biochem. 2013 Mar;114(3):589-98. doi: 10.1002/jcb.24396.

引用本文的文献

1
PIASy deficiency mitigates thoracic aortic aneurysm formation via the TGF-β/Smad2/3 pathway.
J Thorac Dis. 2025 May 30;17(5):3400-3409. doi: 10.21037/jtd-2025-984. Epub 2025 May 28.
3
PIAS family gene expression: implications for prognosis, immunomodulation, and chemotherapy response.
Am J Transl Res. 2024 Nov 15;16(11):6346-6364. doi: 10.62347/JRDP4018. eCollection 2024.
4
Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma.
Front Immunol. 2024 Oct 31;15:1483721. doi: 10.3389/fimmu.2024.1483721. eCollection 2024.
5
The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy.
Biomedicines. 2024 Oct 21;12(10):2408. doi: 10.3390/biomedicines12102408.
8
Exploring the Role of Unconventional Post-Translational Modifications in Cancer Diagnostics and Therapy.
Curr Protein Pept Sci. 2024;25(10):780-796. doi: 10.2174/0113892037274615240528113148.
9
10
PIAS family in cancer: from basic mechanisms to clinical applications.
Front Oncol. 2024 Mar 25;14:1376633. doi: 10.3389/fonc.2024.1376633. eCollection 2024.

本文引用的文献

1
A comprehensive compilation of SUMO proteomics.
Nat Rev Mol Cell Biol. 2016 Sep;17(9):581-95. doi: 10.1038/nrm.2016.81. Epub 2016 Jul 20.
2
PIAS1 Promotes Lymphomagenesis through MYC Upregulation.
Cell Rep. 2016 Jun 7;15(10):2266-2278. doi: 10.1016/j.celrep.2016.05.015. Epub 2016 May 26.
3
PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer.
Neoplasia. 2016 May;18(5):282-293. doi: 10.1016/j.neo.2016.03.003. Epub 2016 Apr 16.
4
SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
Sci Rep. 2016 May 23;6:26509. doi: 10.1038/srep26509.
5
Pias1 is essential for erythroid and vascular development in the mouse embryo.
Dev Biol. 2016 Jul 1;415(1):98-110. doi: 10.1016/j.ydbio.2016.04.013. Epub 2016 May 4.
6
Pharmacological treats for SUMO addicts.
Pharmacol Res. 2016 May;107:390-397. doi: 10.1016/j.phrs.2016.01.004. Epub 2016 Jan 24.
9
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.
Blood. 2014 Sep 25;124(13):2081-90. doi: 10.1182/blood-2014-06-584524. Epub 2014 Aug 20.
10
FAK in cancer: mechanistic findings and clinical applications.
Nat Rev Cancer. 2014 Sep;14(9):598-610. doi: 10.1038/nrc3792. Epub 2014 Aug 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验